Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Cost of Revenue (2021 - 2025)

Historic Cost of Revenue for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to $9.6 million.

  • MDxHealth's Cost of Revenue rose 570.67% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.6 million, marking a year-over-year increase of 1293.62%. This contributed to the annual value of $50.2 million for FY2024, which is 372015.21% up from last year.
  • Latest data reveals that MDxHealth reported Cost of Revenue of $9.6 million as of Q3 2025, which was up 570.67% from $9.0 million recorded in Q2 2025.
  • MDxHealth's Cost of Revenue's 5-year high stood at $9.6 million during Q3 2025, with a 5-year trough of -$3.3 million in Q2 2022.
  • For the 5-year period, MDxHealth's Cost of Revenue averaged around $6.2 million, with its median value being $6.8 million (2023).
  • In the last 5 years, MDxHealth's Cost of Revenue skyrocketed by 30747.82% in 2023 and then soared by 185.96% in 2025.
  • MDxHealth's Cost of Revenue (Quarter) stood at $3.2 million in 2021, then skyrocketed by 75.67% to $5.7 million in 2022, then rose by 18.7% to $6.7 million in 2023, then soared by 37.09% to $9.2 million in 2024, then increased by 3.64% to $9.6 million in 2025.
  • Its last three reported values are $9.6 million in Q3 2025, $9.0 million for Q2 2025, and $8.8 million during Q1 2025.